Global Feline Atopic Dermatitis Treatment Market Expected to Reach USD 7 Billion by 2032, Reports Future Market Insights

Future Market Insights (FMI) has released a comprehensive report on the global feline atopic dermatitis treatment market, projecting a positive 4.5% Compound Annual Growth Rate (CAGR) during the assessment period of 2022-2032. The market, which was valued at USD 5 billion by the end of 2022, is expected to surge to USD 7 billion by 2032.

The rising adoption of cats as companion pets worldwide is cited as the primary driver behind the market’s growth. With more households welcoming feline friends into their lives, the prevalence of atopic dermatitis in cats is on the rise.

Get Access to Sample Now:

“Atopic dermatitis, characterized by skin inflammation in cats, is predominantly triggered by causative allergens, either inhaled or through skin contact,” explains a spokesperson from FMI. “As per the Canadian Veterinary Journal, the prevalence of atopic dermatitis in cats exceeds 12.5%. This condition not only causes distress but also results in fur loss and discomfort for our feline companions.”

Professionals are increasingly resorting to steroid and antibiotic treatments to alleviate the symptoms of atopic dermatitis in cats. Given their cost-effectiveness and efficacy, the corticosteroids segment is expected to witness significant traction over the forecast period.

“To address the burgeoning incidence of atopy in cats, the use of steroids and antibiotics has become commonplace,” adds the spokesperson. “These treatments aim to reduce itchiness and fur loss, thereby enhancing the quality of life for affected felines.”

The FMI report provides valuable insights into market dynamics, including key trends, growth drivers, challenges, and opportunities shaping the global feline atopic dermatitis treatment landscape.

Rising Feline Atopic Dermatitis Treatments Market Driven by Pet Love and Growing Veterinary Care:

This surge in the feline atopic dermatitis treatment market is fueled by several key trends:

  • More Cats in Our Homes: Pet adoption statistics are purrfectly positive! The National Kitten Coalition reports a staggering 1.3 million cats finding loving homes around the world each year. With more cats becoming cherished members of the family, pet parents are increasingly attentive to their feline companions’ health.
  • Focus on Feline Allergies: Alongside rising cat adoptions, there’s a growing awareness of allergies and other health conditions in felines. Atopic dermatitis, a type of skin allergy, is a prevalent concern for cat owners. This heightened awareness translates to a greater demand for effective treatment options.
  • Veterinary Expertise on the Rise: Developed regions like North America and Europe are witnessing a significant increase in the number of veterinarians. This expanded veterinary care infrastructure provides easier access to diagnosis and treatment for feline atopic dermatitis, further propelling the market forward.

The feline atopic dermatitis treatment market is poised for significant growth, driven by the increasing number of cat adoptions, rising awareness of feline allergies, and a growing veterinary healthcare sector. This positive trend ensures that our feline friends can receive the best possible care to keep their fur healthy and their purrs strong.

Request Customization of Report:

Key Companies Profiled:

  • Bausch Health Companies Inc.
  • Bayer AG
  • Pfizer Inc.
  • Novartis AG
  • Eli Lily Company
  • Sanofi
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH

Key Segments Profiled in the Feline Atopic Dermatitis Treatment Industry Survey:

By Drug Class:

  • Corticosteroids
  • Antihistamines
  • Antibiotics

By Route of Administration:

  • Oral
  • Topical
  • Injectable

By Distribution Channel:

  • Veterinary Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • Japan
  • Middle East and Africa

A Detailed Full Report:

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Matched content

Editor’s pick

Express Press Release Distribution